{"transactions":[{"id":937150,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-01-16T17:00:10.000Z","date":"2026-01-10","kind":"exercise","planned":false,"acquired":false,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3430},"source":{"system":"sec-edgar","filing":"0001193125-26-015489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000119312526015489/ownership.xml","form_type":"4"}},{"id":937149,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T17:00:10.000Z","date":"2026-01-10","kind":"exercise","planned":false,"acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issuable on settlement of restricted stock units (\"RSUs\") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026."}],"balance_after":3430,"source":{"system":"sec-edgar","filing":"0001193125-26-015489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000119312526015489/ownership.xml","form_type":"4"}},{"id":1304303,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-13T17:30:10.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":3430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the total restricted stock units will vest on January 10, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the total restricted stock units will vest on January 10, 2026."}],"balance_after":3430,"derivative":{"underlying":"Common Stock","underlying_shares":3430},"source":{"system":"sec-edgar","filing":"0000950170-25-004924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000095017025004924/ownership.xml","form_type":"4"}},{"id":1304302,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-13T17:30:10.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":30870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 30,870 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026."}],"balance_after":30870,"derivative":{"exercise_price":4.04,"expiration_date":"2035-01-10","underlying":"Common Stock","underlying_shares":30870},"source":{"system":"sec-edgar","filing":"0000950170-25-004924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000095017025004924/ownership.xml","form_type":"4"}},{"id":1908283,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-02T18:44:49.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":150437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on May 1, 2024 and with respect to 75,218 shares on May 1, 2025."}],"balance_after":150437,"derivative":{"exercise_price":2.3,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":150437},"source":{"system":"sec-edgar","filing":"0001209191-23-026727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000120919123026727/doc4.xml","form_type":"4"}},{"id":2036068,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T18:08:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2024."}],"balance_after":20000,"derivative":{"exercise_price":3.08,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-006355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000120919123006355/doc4.xml","form_type":"4"}},{"id":2416635,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T17:35:01.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2023."}],"balance_after":20000,"derivative":{"exercise_price":3.97,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-006480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000120919122006480/doc4.xml","form_type":"4"}},{"id":3031305,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-15T20:10:23.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":1167.21,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 1,167.21 shares of the Issuer's Series X1 Convertible Preferred Stock, which will vest in equal monthly installments over two years, subject to the Reporting Person's continued service to the Issuer through each vesting date. The Reporting Person's ability to exercise the option will be subject to stockholder approval under Nasdaq Marketplace Rule 5635(c)."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Series X1 Convertible Preferred Stock will be convertible into 1,000 shares of Common Stock upon receipt of the requisite approval of the stockholders of the Issuer."}],"balance_after":1167.21,"derivative":{"exercise_price":500,"expiration_date":"2030-09-11","underlying":"Series X1 Convertible Preferred Stock","underlying_shares":1167.21},"source":{"system":"sec-edgar","filing":"0000899243-20-025165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000089924320025165/doc4.xml","form_type":"4"}},{"id":3461914,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-15T16:06:04.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":0.88,"exercise_date":"2020-07-11","expiration_date":"2029-07-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-019601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000089924319019601/doc4.xml","form_type":"4"}},{"id":3893955,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-14T17:52:15.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":9100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9100,"derivative":{"exercise_price":6.18,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":9100},"source":{"system":"sec-edgar","filing":"0000899243-18-016652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000089924318016652/doc4.xml","form_type":"4"}},{"id":4264529,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":69246,"kind":"person","name":"McBride John S.","position":1,"cik":"0001618251","reported_name":"McBride John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-05T16:07:05.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock. The shares will vest ratably each quarter over three years beginning on June 30, 2017."}],"balance_after":18000,"derivative":{"exercise_price":5.85,"expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-17-017764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618251/000089924317017764/doc4.xml","form_type":"4"}}]}